vancomycin hydrochloride
Phase 3Small molecule
vancomycin hydrochloride is one of 12 small molecule programs targeting Dental Caries. It is currently in Phase 3.
2
Indications
5
Total Trials
2
Active Trials
11
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
15 competitors in Dental Caries
#DrugCompanyPhaseTrials
1Peridex
DDexcel Pharma Technologies Ltd.
Approved
Mycostatin
GGood Molecules, LLC
Approved
Betadine
BBecton, Dickinson and Company
Approved
Zocor
OOrganon and Co
Approved
Peridex
MMedline Industries
Phase 3
Fluoride Varnish
TThe University of Hong Kong
Approved
vancomycin hydrochloride
WWake Forest University Health Sciences
Phase 3
Calcium Hydroxide
MMansoura University
Phase 2
Chlorhexidine Digluconate
GSKPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Dental Caries1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for vancomycin hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details